Janus Henderson Group PLC Buys 89,400 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Janus Henderson Group PLC increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 12.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 834,278 shares of the company’s stock after purchasing an additional 89,400 shares during the period. Janus Henderson Group PLC owned approximately 0.18% of GE HealthCare Technologies worth $75,832,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Kennedy Capital Management LLC lifted its position in GE HealthCare Technologies by 23.3% during the 1st quarter. Kennedy Capital Management LLC now owns 156,183 shares of the company’s stock worth $14,199,000 after buying an additional 29,543 shares in the last quarter. Bayesian Capital Management LP bought a new stake in shares of GE HealthCare Technologies in the 1st quarter valued at about $8,209,000. Blackstone Inc. acquired a new stake in GE HealthCare Technologies in the 1st quarter valued at about $31,818,000. Silvercrest Asset Management Group LLC grew its holdings in GE HealthCare Technologies by 31.9% during the first quarter. Silvercrest Asset Management Group LLC now owns 586,663 shares of the company’s stock worth $53,334,000 after purchasing an additional 141,888 shares during the period. Finally, Sandia Investment Management LP acquired a new position in GE HealthCare Technologies during the first quarter worth approximately $1,000,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on GEHC shares. Evercore ISI raised their target price on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. Bank of America lowered their target price on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. Citigroup increased their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. The Goldman Sachs Group began coverage on shares of GE HealthCare Technologies in a report on Thursday, May 30th. They set a “neutral” rating and a $87.00 price target for the company. Finally, Mizuho lowered their price objective on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research report on Wednesday, May 1st. Five equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $94.09.

Insider Buying and Selling

In other GE HealthCare Technologies news, CTO Taha Kass-Hout sold 3,300 shares of the stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total transaction of $259,710.00. Following the completion of the transaction, the chief technology officer now owns 67,300 shares in the company, valued at $5,296,510. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other GE HealthCare Technologies news, CEO Jan Makela sold 66,955 shares of the business’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $81.54, for a total transaction of $5,459,510.70. Following the sale, the chief executive officer now owns 63,348 shares of the company’s stock, valued at approximately $5,165,395.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CTO Taha Kass-Hout sold 3,300 shares of the firm’s stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total value of $259,710.00. Following the completion of the transaction, the chief technology officer now directly owns 67,300 shares of the company’s stock, valued at $5,296,510. The disclosure for this sale can be found here. In the last 90 days, insiders sold 90,482 shares of company stock valued at $7,369,137. 0.27% of the stock is owned by insiders.

GE HealthCare Technologies Trading Up 4.2 %

Shares of GE HealthCare Technologies stock traded up $3.44 on Wednesday, hitting $86.09. 3,245,287 shares of the company’s stock traded hands, compared to its average volume of 3,101,594. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.06 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.50. The company has a fifty day moving average of $78.67 and a two-hundred day moving average of $82.31. The company has a market capitalization of $39.30 billion, a price-to-earnings ratio of 24.38, a price-to-earnings-growth ratio of 2.95 and a beta of 1.20.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.90. The business had revenue of $4.65 billion for the quarter, compared to the consensus estimate of $4.80 billion. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The firm’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.85 EPS. As a group, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be paid a dividend of $0.03 per share. The ex-dividend date is Friday, July 19th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s payout ratio is 3.51%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.